智翔金泰股价跌5.08%，天治基金旗下1只基金重仓，持有1.75万股浮亏损失3.29万元

Group 1 - The core point of the article highlights the recent decline in the stock price of Zhixiang Jintai, which fell by 5.08% to 35.14 CNY per share, with a trading volume of 221 million CNY and a turnover rate of 5.26%, resulting in a total market capitalization of 12.885 billion CNY [1] - Zhixiang Jintai Biopharmaceutical Co., Ltd. is located in Chongqing and was established on October 20, 2015, with its listing date on June 20, 2023. The company's main business involves the research, production, and sales of antibody drugs, with 99.92% of its revenue coming from antibody drugs and 0.08% from other supplementary sources [1] Group 2 - From the perspective of fund holdings, Tianzhi Fund has one fund heavily invested in Zhixiang Jintai. Tianzhi New Consumption Mixed Fund (350008) held 17,500 shares in the second quarter, accounting for 2.59% of the fund's net value, ranking as the tenth largest holding. The estimated floating loss today is approximately 32,900 CNY [2] - Tianzhi New Consumption Mixed Fund (350008) was established on August 4, 2011, with a latest scale of 18.7694 million CNY. Year-to-date returns are 11.21%, ranking 5600 out of 8184 in its category, while the one-year return is 7.51%, ranking 7154 out of 7971. Since its inception, the fund has experienced a loss of 8.54% [2] - The fund manager of Tianzhi New Consumption Mixed Fund is Liang Li, who has been in the position for 4 years and 142 days. The total asset scale under management is 71.0539 million CNY, with the best fund return during the tenure being 11.55% and the worst being -59.11% [2]